Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
histamine/krabbamein
Krækjan er vistuð á klemmuspjaldið
Bls 1 frá 22 niðurstöður
Combined anti-tumor therapy with interleukin-2 and histamine, analogs thereof or H.sub.2 -receptor agonists
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
TECHNICAL FIELD
This invention relates to the field of anti-tumor therapy, and more particularly to the treatment of malignant tumors with interleukin-2 (IL-2). The improvement provided by the present method is the co-administration of the IL-2 with an agent such as histamine, histamine structural
Synergistic tumorcidal response induced by histamine
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
The present invention relates to methods of treating cancer in which histamine is administered in conjunction with other cancer therapies. The cancer therapy includes surgery, radiation, immunotherapy, the administration of an agent which enhances the humoral immune response
Treatment method for cancer
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF INVENTION
The present invention relates to the improved treatment of cancer in animals, including humans, using chemotherapeutic agents.
BACKGROUND TO THE INVENTION
One of the major chemotherapeutic treatments is that of malignant growth (cancer) in humans. The objective of chemotherapy is
Treatment method for cancer
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF INVENTION
The present invention relates to the improved treatment of cancer in animals, including humans, using chemotherapeutic agents.
BACKGROUND TO THE INVENTION
One of the major chemotherapeutic treatments is that of malignant growth (cancer) in humans. The objective of chemotherapy is
Treatment method for cancer
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF INVENTION
The present invention relates to the improved treatment of cancer in animals, including humans, using chemotherapeutic agents.
BACKGROUND TO THE INVENTION
One of the major chemotherapeutic treatments is that of malignant growth (cancer) in humans. The objective of chemotherapy is
Treatment method for cancer
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF INVENTION
The present invention relates to the improved treatment of cancer in animals, including humans, using chemotherapeutic agents.
BACKGROUND TO THE INVENTION
One of the major chemotherapeutic treatments is that of malignant growth (cancer) in humans. The objective of chemotherapy is
Method for treatment of cancer and infectious disease
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
The present invention concerns a pharmaceutical preparation or system for activation of natural killer cells (NK-cells), in order, for example, to treat tumors or virus infections.
SUMMARY OF THE INVENTION
Natural killer cells (NK-cells) are a group of spontaneously cytotoxic
Method for treatment of cancer and infectious disease
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
The present invention concerns a pharmaceutical preparation or system for activation of natural killer cells (NK-cells), in order, for example, to treat tumors or virus infections.
SUMMARY OF THE INVENTION
Natural killer cells (NK-cells) are a group of spontaneously cytotoxic
Preparation for activation of natural killer cells (NK-cells), said preparation containing interferon-alpha and histamine, serotonin, amines or substances with corresponding receptor activity
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
The present invention concerns a pharmaceutical preparation or system for activation of natural killer cells (NK-cells), in order for example, to treat tumors or virus infections.
BACKGROUND OF THE INVENTION
Natural killer cells (NK-cells) are a group of spontaneously
Histamine-releasing factor (HRF), HRF-receptor and methods of modulating inflammation
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted electronically in ASCII format and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Aug. 18, 2014, is named LIAI0433629_ST25.txt and is 21,069 bytes in
Substituted tricyclic heterocycles as histamine 4 receptor inhibitors
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a national phase application of PCT Application No. PCT/KR2012/007965, filed on Sep. 28, 2012, which claims the benefit and priority to Korean Patent Application No. 10-2011-0100369, filed Sep. 30, 2011 and claims the benefit and priority
Composition for treating hormonally-dependent cancers
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary
Method for treatment of cancer and infectious disease
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
The present invention concerns a pharmaceutical preparation or system for activation of natural killer cells (NK-cells), in order, for example, to treat tumors or virus infections.
BACKGROUND OF THE INVENTION
Natural killer cells (NK-cells) are a group of spontaneously
Immunomodulating and antiinflammatory agent
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
The present invention relates to the use of a histamine-added gamma-globulin as pharmaceuticals. More particularly, it relates to an immunomodulating agent, a suppressive agent to hypereosinophilicity and an antiinflammatory agent containing the histamine-added gamma-globulin
Immunomodulating and antiinflammatory agent
Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION
The present invention relates to the use of a histamine-added gamma-globulin as pharmaceuticals. More particularly, it relates to an immunomodulating agent, a suppressive agent to hypereosinophilicity and an antiinflammatory agent containing the histamine-added gamma-globulin
Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum
- Virkar á 55 tungumálum
- Jurtalækningar studdir af vísindum
- Jurtaviðurkenning eftir ímynd
- Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
- Lestu vísindarit sem tengjast leit þinni
- Leitaðu að lækningajurtum eftir áhrifum þeirra
- Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum
Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum
